Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 2002

View Archived Issues

Devgen enters into target validation collaboration with Genentech

Celexa's marketing exclusivity extended by six months

Xyrem approved for cataplexy associated with narcolepsy

Advicor marketing application submitted in Europe

Genome to advance two lead compound series from ArQule collaboration into optimization

Deltagen discovers drug target with potential in rheumatoid arthritis

First radiolabeled probe for imidazoline I1 receptors

NO-donating, selective COX-2 inhibitor with beneficial cardiovascular profile

Novel thymulin-related peptide with antihyperalgesic/analgesic effects in rat models

Flupirtine improves cognition in Creutzfeldt-Jakob disease patients

Multiple neuroprotective actions described for dehydroevodiamine in Stockholm

Early clinical results discussed for lipid A antagonist at IUPHAR 2002

New Tie-2 and/or VEGFR-2 inhibitors and their use in cancer

Pfizer identifies carbazole NPY Y5 antagonists

Yamanouchi presents novel apo B secretion inhibitors for lipoprotein disorders

Cyclophilin ligands with neurotrophic activity reported by Guilford

Selective PARP1/PARP2 inhibitors described by Iconix R&D team

A new carrageenan-based microbicide gel for sexually transmitted diseases

New lanosterol synthase inhibitors under study at Roche

Synthesis and use of dopamine D3 antagonists as antipsychotics described in recent patent

SomatoKine granted orphan drug status in GH insensitivity syndrome

PD-166793 inhibition of MMP attenuates volume overload-induced myocardial remodeling

Phase IIa results of DX-890 in cystic fibrosis

TAK-456 shows potential in the treatment of candidiasis and aspergillosis

Phase II Aroplatin trial enrolling in metastatic colorectal cancer

FDA committee recommends Atacand superiority claim on label

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...